Department of Molecular Pharmacology, School of Medicine, Nankai University, Tianjin, China.
Department of Pathogen Biology, School of Basic Medical Science, Tianjin Medical University, Tianjin, China.
Oncoimmunology. 2021 Nov 23;10(1):2004659. doi: 10.1080/2162402X.2021.2004659. eCollection 2021.
Numerous studies have found that chronic stress could promote tumor progression and this may be related to inhibtion of immune system. Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of cells with immunosuppressive activity. MDSCs may represent a key link between chronic stress and tumor progression. However, the role of stress-induced MDSCs in breast cancer progression is unclear. The present study showed that pre-exposure of chronic stress could lead to MDSCs elevation and facilitated breast cancer metastasis in tumor-bearing mice. Adoptive transfer of MDSCs could significantly increase lung metastatic foci. In contrast, lung metastasis could be alleviated by depleting endogenous MDSCs with Gr-1 antibody. The concentration of norepinephrine in serum and the expression of tyrosine hydroxylase in bone marrow could be significantly elevated by chronic stress. Moreover, propranolol, an inhibitor of β-adrenergic signaling, could inhibit breast carcinoma metastasis and prevent the expansion of chronic stress-induced MDSCs. Further study revealed that the expressions of IL-6 and JAK/STAT3 signaling pathways were upregulated by chronic stress in mice, and this upregulation could be inhibited by propranolol. Blocking the IL-6 signal or inhibiting the activation of the JAK/STAT3 signaling pathway could reduce tumor growth and metastasis by attenuating the accumulation of MDSCs in vivo. Besides, propranolol inhibited the expression of IL-6 in supernatant of 4T1 cells induced by isoproterenol and reduced the proportion of inducible MDSCs in vitro. Taken together, these data indicated that chronic stress may accumulate MDSCs via activation of β-adrenergic signaling and IL-6/STAT3 pathway, thereby promoting breast carcinoma metastasis.
大量研究发现慢性应激可促进肿瘤进展,这可能与免疫系统抑制有关。髓系来源的抑制细胞(MDSCs)是具有免疫抑制活性的异质性细胞群体。MDSCs 可能代表慢性应激与肿瘤进展之间的关键联系。然而,应激诱导的 MDSCs 在乳腺癌进展中的作用尚不清楚。本研究表明,慢性应激前暴露可导致 MDSCs 升高,并促进荷瘤小鼠乳腺癌转移。MDSCs 的过继转移可显著增加肺转移灶。相比之下,用 Gr-1 抗体耗尽内源性 MDSCs 可减轻肺转移。慢性应激可显著增加血清去甲肾上腺素浓度和骨髓酪氨酸羟化酶的表达。此外,β-肾上腺素能信号的抑制剂普萘洛尔可抑制乳腺癌转移,并防止慢性应激诱导的 MDSCs 扩张。进一步研究表明,慢性应激可使小鼠体内的 IL-6 和 JAK/STAT3 信号通路表达上调,而普萘洛尔可抑制这种上调。阻断 IL-6 信号或抑制 JAK/STAT3 信号通路的激活可通过减轻 MDSCs 在体内的积累来减少肿瘤生长和转移。此外,普萘洛尔可抑制异丙肾上腺素诱导的 4T1 细胞上清液中 IL-6 的表达,并减少体外诱导型 MDSCs 的比例。综上所述,这些数据表明慢性应激可能通过激活β-肾上腺素能信号和 IL-6/STAT3 通路来积累 MDSCs,从而促进乳腺癌转移。